AI assistant
PFIZER INC — Director's Dealing 2022
Mar 1, 2022
29831_dirs_2022-03-01_e1d18e5a-4315-4fae-bb63-d96eb74f79d6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2022-02-28
Reporting Person: SAHNI PAYAL (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-28 | Common Stock | F | 1049.0000 | $46.9400 | Disposed | 18753.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-28 | Phantom Stock Units | $ | A | 4295.0000 | Acquired | Common Stock (4295.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 9718.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
F2: Each unit represents one phantom share of common stock.
F3: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon) which have been deferred into the Pfizer Inc. Deferred Compensation Plan.
F4: The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.